CRBP Corbus Pharmaceuticals Holdings Inc.

6.85
-0.27  -4%
Previous Close 7.12
Open 7.13
Price To Book 10.38
Market Cap 441,518,264
Shares 64,455,221
Volume 703,939
Short Ratio
Av. Daily Volume 895,040

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2b data due 2020.
Anabasum (Resunab)
Cystic Fibrosis
Phase 2 trial initiation announced December 22, 2017.
Anabasum (Resunab)
Systemic lupus erythematosus (SLE)
Phase 3 trial initiation announced December 17, 2018.
Lenabasum (resunab)
Dermatomyositis
Phase 3 top-line data due summer 2020.
Resunab
Systemic Sclerosis
Phase 2 open label data presented at EULAR June 14, 2019.
Lenabasum (resunab)
Systemic Sclerosis

Latest News

  1. Corbus Pharmaceuticals to Host 2019 R&D Day in New York City
  2. Understanding Medical Cannabis vs. Recreational Cannabis Stocks
  3. Lenabasum Open-Label Extension Data to be Presented at EULAR 2019 Continue to Show a Favorable Safety Profile and Improvement in Efficacy Outcomes in Systemic Sclerosis and Dermatomyositis Phase 2 Studies
  4. Edited Transcript of CRBP earnings conference call or presentation 9-May-19 12:30pm GMT
  5. Robbins Arroyo LLP: Corbus Pharmaceuticals Holdings, Inc. (CRBP) Sued for Misleading Shareholders
  6. Top Marijuana Stocks on the NASDAQ
  7. Corbus Pharmaceuticals to Present at Two Upcoming Investor Conferences in June
  8. Corbus Pharmaceuticals Announces Presentation of Six Abstracts at EULAR 2019 Annual Meeting
  9. Does Corbus Pharmaceuticals Holdings, Inc.'s (NASDAQ:CRBP) CEO Pay Compare Well With Peers?
  10. Is Corbus Pharmaceuticals a Buy Now?
  11. Corbus Pharmaceuticals to Present at Two Upcoming Investor Conferences in May
  12. SHAREHOLDER ALERT: CRBP FSNN MWA AAPL: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
  13. CRBP, NIO & CORT Deadline Alert - Bronstein, Gewirtz & Grossman, LLC Class Action
  14. FINAL DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Corbus Pharmaceuticals Holdings, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
  15. The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of NIO, CRBP, ARA and NTNX
  16. 3-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Corbus Pharmaceuticals Holdings, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
  17. Bronstein, Gewirtz & Grossman, LLC Class Action Update: BPI, CRBP & NIO
  18. FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of CRBP, ZGNX and BSX
  19. DEADLINE MONDAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Corbus Pharmaceuticals Holdings, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm